Abstract
ABO-incompatible transplants are rare but have been successfully performed in liver [1–3], heart [4], kidney [5, 6], and pancreas [7] transplants. ABO-incompatible transplants are usually performed only in life-threatening emergencies or in the presence of special immunologic conditions. One such condition is a transplant from blood group A2 donors to blood group 0 recipients. Its feasibility is based on the low expression of A2 (vs Al) determinants. Favorable outcome of A2 organs transplanted into 0 recipients had already been reported in the early 1980s [8, 9]. The recipient’s IgM anti-A2 titer appeared to be a key factor: Transplants with titers <1:64 usually succeeded, whereas titers ≥1:64 tended to fail. To avoid hyperacute rejection, prospective ABO-incompatible recipients require additional treatment: elimination of ABO isoagglutinins by plasmapheresis or immunoadsorption with or without concurrent recipient splenectomy [10, 11]. Removal of antiblood group IgM isoagglutinins prevents the development of hyperacute rejection early posttransplant; the return of those isoagglutinins after several weeks posttransplant appears to have no effect on graft function.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gordon R, Iwatsuki S, Esquivel C, et al. Liver transplantation across ABO blood groups. Surgery. 1986;100:342–8.
Gugenheim J, Samuel D, Reynes M, et al. Liver transplantation across ABO blood group barriers. Lancet. 1990;336:519–22.
Farges O, Kalil A, Samuel D, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation. 1995;59:1124–33.
Caruana R, Zumbro G, Hoff R, et al. Successful cardiac transplantation across an ABO blood group barrier. Transplantation. 1988;46:472–4.
Starzl TE, Marchioro TL, Holmes JH, et al. Renal homografts in patients with major donor-recipient group incompatibilities. Surgery. 1964;55:195–200.
Tanabe K, Takahashi K, Sonda K, et al. Long-term results of ABO-incompatible living kidney transplantation. Transplantation. 1998;65:224–8.
Kandaswamy R, Humar A, Wijkstrom M, Eastlund T, Sutherland DER. ABO-incompatible, living unrelated, simultaneous pancreas and kidney transplant: a case report. In: Abstract Book of the 7th World Congress of the International Pancreas and Islet Association, Sydney, Australia, 1999. p. 69.
Brynger H, Rydberg L, Samuelsson B, et al. Renal transplantation across a blood group barrier-“A2” kidneys to “0” recipients. Proc Eur Dial Transplant Assoc. 1982;19:427–31.
Alexandre GPJ, Squifflet JP. Significance of the ABO antigen system. In: Cirelli GJ, editor. Organ transplantation and replacement. Philadelphia: JB Lippincott; 1988. p. 223–30.
Alexandre GPJ, Latinne D, Carlier M, et al. ABO-incompatibility and organ transplantation. Transplant Rev. 1991;5:230–41.
Mendez R, Sakhrani L, Aswad S, et al. Successful living-related ABO incompatible renal transplant using the BIOSYNSORB immunoadsorption column. Transplant Proc. 1992;24:1738–40.
Slapak M, Naik RM, Lee HA. Renal transplant in patients with major donor-recipient blood group incompatibility. Transplantation. 1981;31:4–7.
Bannet AD, McAlack RF, Raja R, et al. Experiences with known ABO-mismatched renal transplants. Transplant Proc. 1987;19:4543–6.
Alexandre GPJ, Squifflet JP, DeBruyere M, et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc. 1985;17:138–43.
Sindhi R, Landmark J, Stratta RJ, Cushing K, Taylor R. Humoral graft-versus-host disease after pancreas transplantation with an ABO-compatible and Rh-nonidentical donor. Transplantation. 1996;1:1414–6.
Kong JM, Park AJ, Chung BH, Yang J, Huh KH, Kim JM. ABO incompatible living donor kidney transplantation in Korea. Clin Transplant. 2013;27:875.
Kwon H, Kim JY, Kim DH, Ko Y, Choi JY, Shin S, Jung JH, Kim YH, Han DJ, Korean Organ Transplantation Registry Study Group. Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study. Sci Rep. 2019;9(1):18229.
Tagarelli A, Landsteiner K. A hundred years later. Transplantation. 2001;72:3–7.
Alexandre GP, De Bruyere M, Squifflet JP, Moriau M, Latinne D, Pirson Y. Human ABO-incompatible living donor renal homografts. Neth J Med. 1985;28(6):231–4.
Reding R, Squifflet JP, Pirson Y, Jamart J, De Bruyère M, Moriau M, Latinne D, Carlier M, Alexandre GP. Living-related and unrelated donor kidney transplantation: comparison between ABO-compatible and incompatible grafts. Transplant Proc. 1987;19(1 Pt 2):1511–3.
Takahashi K, Tanabe K, Ooba S, Yagisawa T, Nakazawa H, Teraoka S, Hayasaka Y, Kawaguchi H, Ito K, Toma H. Prophylactic use of a new immunosuppressive agent, deoxyspergualin, in patients with kidney transplantation from ABO-incompatible or preformed antibody-positive donors. Transplant Proc. 1991;23(1 Pt 2):1078–82.
Ota K, Takahashi K, Agishi T, Sonda T, Oka T, Ueda S, Amemiya H, Shiramizu T, Okazaki H, Akiyama N, Hasegawa A, Kawamura T, Takagi H, Ueno A. Multicentre trial of ABO-incompatible kidney transplantation. Japanese Biosynsorb ABO-incompatible kidney transplant study group. Transpl Int. 1992;5(Suppl 1):S40–3. https://doi.org/10.1007/978-3-642-77423-2_13. PMID: 14628736.
Tanabe K, Takahashi K, Sonda K, Tokumoto T, Ishikawa N, Kawai T, Fuchinoue S, Oshima T, Yagisawa T, Nakazawa H, Goya N, Koga S, Kawaguchi H, Ito K, Toma H, Agishi T, Ota K. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation. 1998;65(2):224–8. https://doi.org/10.1097/00007890-199801270-00014. PMID: 9458019.
Takahashi K, Saito K, Takahara S, Okuyama A, Tanabe K, Toma H, Uchida K, Hasegawa A, Yoshimura N, Kamiryo Y, Japanese ABO-Incompatible Kidney Transplantation Committee. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant. 2004;4(7):1089–96. https://doi.org/10.1111/j.1600-6143.2004.00464.x. PMID: 15196066.
Bannett AD, Bensinger WI, Raja R, Baquero A, McAlack RF. Immunoadsorption and renal transplant in two patients with a major ABO incompatibility. Transplantation. 1987;43:909–11.
Ota K, Takahashi K, Agishi T, et al. Multicentre trial of ABO-incompatible kidney transplantation. Transplant Int. 1992;5:40–3.
Takahashi K. A review of humoral rejection in ABO-incompatible kidney transplantation, with local (intrarenal) DIC as the underlying condition. Acta Medica Biol. 1997;45:95–102.
Takahashi K, Saito K, Takahara S, Fuchinoue S, Yagisawa T, Aikawa A, Watarai Y, Yoshimura N, Tanabe K, Morozumi K, Shimazu M, IDEC-C2B8 ABO-I KTx Study Group. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation. Clin Exp Nephrol. 2017;21(4):705–13. https://doi.org/10.1007/s10157-016-1321-5. Epub 2016 Aug 17. PMID: 27534951.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Han, DJ., Kenmochi, T. (2022). History of ABO Incompatible Pancreas Transplantation. In: Han, DJ., Kenmochi, T., Shyr, YM. (eds) Pancreas Transplantation – the Asian Experience. Springer, Singapore. https://doi.org/10.1007/978-981-16-4597-6_17
Download citation
DOI: https://doi.org/10.1007/978-981-16-4597-6_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-4596-9
Online ISBN: 978-981-16-4597-6
eBook Packages: MedicineMedicine (R0)